They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Analysts covering Merck predict earnings growth of 17.6% in 2025 and an additional 10.4% increase in 2026. With shares currently trading at seven times forward 2025 earnings, Merck appears to be an ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Merck & Co. Inc. (NYSE: MRK) resulting from allegations ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. securities between February 3, 2022 and February 3, 2025, inclusive (the "Class Period"), ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their ...

Booming AI budgets seemed at risk last week when DeepSeek crashed Nvidia’s stock based on speculation that its cheaper AI models would lower demand for AI chips and data centers. Alphabet CEO ...

Merck ( NYSE:MRK ) Full Year 2024 Results Key Financial Results Revenue: US$64.2b (up 6.7% from FY 2023). Net income... Shareholders might have noticed that Merck & Co., Inc. ( NYSE:MRK ) filed its ...

After hours: 7:20:20 p.m. EST ...

After hours: 7 February at 7:59:57 pm GMT-5 ...